Moa Life Plus

Moa Life Plus Gross Margin

The Gross Margin of Moa Life Plus (142760.KQ) as of Nov 5, 2026 is 16.52 %. In the previous year, Gross Margin was 29.36 % — a change of -43.73% (lower).

Gross Margin

16.52 %

YoY

-43.73%

Last updated:

Gross Margin of Moa Life Plus is 2025 16.52 % . Gross Margin of Moa Life Plus was 2024 29.36 % . It decreases by -43.73% lower compared to the previous year.

Moa Life Plus's gross margin stands at 16.5%, down from 25.4% several years earlier.

The Moa Life Plus Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
34.13 KRW
Jan 1, 2019
33.44 KRW
Jan 1, 2020
28.16 KRW
Jan 1, 2021
25.43 KRW
Jan 1, 2022
30.87 KRW
Jan 1, 2023
64.54 KRW
Jan 1, 2024
29.36 KRW
Jan 1, 2025
16.52 KRW
The Moa Life Plus Gross Margin history
YEARGross MarginYoY
16.52 %-43.73%
29.36 %-54.51%
64.54 %+109.07%
30.87 %+21.38%
25.43 %-9.68%
28.16 %-15.79%
33.44 %-2.03%
34.13 %+189.52%
11.79 %-61.97%
31.00 %+4.30%
29.72 %-48.62%
57.84 %+42,523.67%
0.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Moa Life Plus Stock analysis

What does Moa Life Plus do? BL Corp. develops biopharmaceutical products and manufactures health functional foods and functional cosmetics. The company distributes Glu 100 Tablets, CellribonQ, and GentaQ to general hospitals and pharmacies. It generates revenue through the sale of these pharmaceuticals and health-related products to healthcare providers and retail outlets. The firm's product portfolio includes Glu 100 Tablets, CellribonQ, and GentaQ, which are distributed to general hospitals and pharmacies. These products are sold as part of the company's pharmaceutical and medical supplies distribution business. Revenue is derived from the sale of these branded medicines and health functional products. BL Corp. focuses on the distribution of specific branded pharmaceuticals and health functional products. The company's primary customers are general hospitals and pharmacies, which purchase Glu 100 Tablets, CellribonQ, and GentaQ for resale or direct use in healthcare settings. Moa Life Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moa Life Plus stock

Gross Margin of Moa Life Plus is 16.52 % in 2025.

Gross Margin of Moa Life Plus changed from 29.36 % to 16.52 %, representing a -43.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Moa Life Plus since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Moa Life Plus with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Moa Life Plus

All Key Metrics — Moa Life Plus